XML 92 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Accrued Liabilities, Current [Abstract]    
Preclinical and clinical trial accruals $ 27,663 $ 57,780
API and bulk drug product price true-up 50,978 75,055
Litigation settlement 28,500 0
Payroll and related accruals 20,267 22,562
Accrued co-promotion expenses - current 10,309 36,677
Roxadustat profit share to AstraZeneca 7,084 7,280
Property taxes and other taxes 6,615 7,691
Professional services 7,103 5,480
Current portion of liability related to sale of future revenues 5,654 0
Accrued restructuring charge 3,697 0
Other 5,021 7,248
Total accrued and other current liabilities $ 172,891 $ 219,773